Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDD5B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $169,298
Award facts
- Contract value 100% obligated
- $169,298.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $169,298.28 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on February 4, 2026, with completion scheduled for February 5, 2026. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company has demonstrated extensive capability in fulfilling federal medical supply needs through its portfolio of delivery orders covering multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This Dupixent delivery order supports the Defense Health Agency and broader military healthcare systems' requirements for immunological treatments and reflects the company's established role in the DLA's pharmaceutical supply chain for military medical facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FDD5B?
SPE2DR26FDD5B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FDD5B worth?
The government has obligated $169,298 on SPE2DR26FDD5B.
Is contract SPE2DR26FDD5B an order under another contract?
Yes. SPE2DR26FDD5B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDD5B competed?
The extent of competition for SPE2DR26FDD5B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award